Skip to content

Author

B. A. Alsel

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

One target, two evidence streams: Rituximab versus ocrelizumab in relapsing multiple sclerosis: A design-stratified systematic review, meta-analysis, and concordance assessment.

PURPOSE Rituximab is widely used off-label as a lower-cost alternative to ocrelizumab for relapsing multiple sclerosis (MS), but comparative effectiveness and safety remain uncertain. We assessed direct head-to-head evidence and concordance between randomized and real-world findings. METHODS PubMed/MEDLINE, Cochrane...

Yehia Nabil, Ahmed Shaheen, Anas Mansour et al. · 0 citations
Review Oct 2026

Transcranial alternating current stimulation for major depressive disorder: An updated systematic review and meta-analysis of randomized trials with GRADE assessment.

PURPOSE Transcranial alternating current stimulation (tACS) may modulate neural oscillations implicated in major depressive disorder (MDD). This systematic review and meta-analysis assessed the efficacy, follow-up effects, tolerability, and safety of tACS in adults with MDD. METHODS PubMed/MEDLINE, CENTRAL, Scopus, W...

Yehia Nabil, Khaled Moghib, Zeyad Tarek et al. · 0 citations
Meta-analysis Open access Sep 2026

Telmisartan-based monotherapy and combination regimens for blood pressure control in adults with hypertension: a systematic review, meta-analysis, and GRADE assessment

Telmisartan-based regimens, particularly fixed-dose and multidrug combinations, effectively reduce office and ambulatory blood pressure and improve blood pressure response, with broadly comparable short-term safety and less edema.

B. A. Alsel, Muzun Saleh Alturqi Alanazi, Aryam Salem Mgairan Alrawaili et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.